NCT06362395View on ClinicalTrials.gov

Ultra-high Dose Radiation for Liver Metastasis Using MR-guided TReatment With Stereotactic Ablative Single-fraction

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2030

Study Completion Date

September 30, 2030

Conditions
Liver Metastases
Interventions
RADIATION

Magnetic resonance (MR)-guided stereotactic ablative single-fraction (SBRT)

Precise radiation therapy delivered in a single session using magnetic resonance imaging for guidance.

All Listed Sponsors
lead

University Health Network, Toronto

OTHER